Zobrazeno 1 - 10
of 2 956
pro vyhledávání: '"Cardiac allograft vasculopathy"'
Autor:
B. L. Mironkov, D. D. Uvarova, N. N. Koloskova, Yu. V. Sapronova, I. I. Muminov, A. A. Yusova, S. A. Sakhovsky
Publikováno v:
Вестник трансплантологии и искусственных органов, Vol 26, Iss 2, Pp 42-47 (2024)
Transplant coronary artery disease (TCAD) is one of the main causes of graft dysfunction and graft loss. Early diagnosis and treatment of cardiac allograft vasculopathy (CAV) can increase graft survival and improve the prognosis for heart transplant
Externí odkaz:
https://doaj.org/article/25d1919c36ac4562922507c32e359f4b
Publikováno v:
Российский кардиологический журнал, Vol 29, Iss 3S (2024)
Introduction. Today, heart failure (HF) is the most common natural outcome of diseases that are not diagnosed and treated in time. Despite the advances in cardiovascular pharmacotherapy, orthotopic heart transplantation is a generally recognized gold
Externí odkaz:
https://doaj.org/article/dfea3359e65e4d66a17a88debbcf9847
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Paediatric heart transplant is an established treatment for end stage heart failure in children, however patients have to commit to lifelong medical surveillance and adhere to daily immunosuppressants to minimise the risk of rejection. Compliance wit
Externí odkaz:
https://doaj.org/article/2ee1639d172c42be996bc2c4b00dd35a
Publikováno v:
Вестник трансплантологии и искусственных органов, Vol 26, Iss 1, Pp 97-102 (2024)
Cardiac allograft vasculopathy (CAV) is a coronary heart disease (CHD), arising after an orthotopic heart transplant (OHT), and it is one of the leading causes of death in heart recipients. The probability of death is 10%. CAV can manifest as early a
Externí odkaz:
https://doaj.org/article/11734bf623304d90add244b766a3556b
Autor:
Rasmus Gebauer Dalsgaard, BMSc, Tor Skibsted Clemmensen, MD, PhD, DMSc, Hans Eiskjær, MD, DMSc, Steen Hvitfeldt Poulsen, MD, DMSc, PhD, Kamilla Pernille Bjerre, MD, PhD
Publikováno v:
JHLT Open, Vol 5, Iss , Pp 100110- (2024)
Background: Long-term survival after heart transplantation (HTx) is limited by cardiac allograft vasculopathy (CAV). The pathogenesis of CAV is poorly understood, and treatment has not yet been well-established. In this exploratory study, we aimed to
Externí odkaz:
https://doaj.org/article/b9defa5b254e4b1f910a2ce8d5ff832e
Autor:
Mario Udovičić, Hrvoje Falak, Miro Raguž, Ilko Vuksanović, Ante Lisičić, Šime Manola, Irzal Hadžibegović
Publikováno v:
Acta Clinica Croatica, Vol 63., Iss Supplement 1, Pp 14-17 (2024)
Cardiac allograft vasculopathy (CAV) is diffuse concentric narrowing caused by intimal fibriproliferation of the coronary arteries in patients after heart transplantation (HTx). It affects almost one third of patients over the period of 5 years, an
Externí odkaz:
https://doaj.org/article/a6d002ae4fec465c9e16ade8142a30a5
Autor:
Antoinette S. Birs, MD, Quan M. Bui, MD, Yan Gernhofer, Antonio Duran, MD, Lucas Keyt, MD, Kevin Paternostro, MD, Jeffrey Ding, Eric Adler, MD, Lawrence Ang, MD, Marcus A. Urey, MD, Mark J. Kearns, MD, Nicholas Wettersten, MD, Victor Pretorius, MBchB
Publikováno v:
JHLT Open, Vol 4, Iss , Pp 100065- (2024)
Background: Cardiac allograft vasculopathy (CAV) accounts for significant long-term morbidity and mortality in heart transplant recipients; limited data exist for donation after circulatory death (DCD). Intravascular ultrasound (IVUS) assessment is a
Externí odkaz:
https://doaj.org/article/dc4cb94a2b7e42e89604202006f5913b
Autor:
Sandro Sponga, Igor Vendramin, Veronica Ferrara, Michela Marinoni, Giulia Valdi, Concetta Di Nora, Chiara Nalli, Giovanni Benedetti, Daniela Piani, Andrea Lechiancole, Maria Parpinel, Uberto Bortolotti, Ugolino Livi
Publikováno v:
Transplant International, Vol 37 (2024)
Metabolic Syndrome (MetS), a multifactorial condition that increases the risk of cardio-vascular events, is frequent in Heart-transplant (HTx) candidates and worsens with immunosuppressive therapy. The aim of the study was to analyze the impact of Me
Externí odkaz:
https://doaj.org/article/8e7e430a813a42219fcafa98720524b7
Autor:
Pooja Prasad, Raj Nagappan, Brian P. Davidson, Kevin Wei, James Hodovan, Jonathan R. Lindner, Johannes Steiner
Publikováno v:
ESC Heart Failure, Vol 10, Iss 5, Pp 3184-3189 (2023)
Abstract Cardiac allograft vasculopathy (CAV) remains a common long‐term complication of cardiac transplantation. While invasive coronary angiography is considered the gold standard, it is also invasive and lacks sensitivity to detect early, distal
Externí odkaz:
https://doaj.org/article/0d8eaaabb5f141148506e7e8673d4c1c
Autor:
Niels Møller Jensen, BSc, Tor Skibsted Clemmensen, MD, PhD, DMSc, Kamilla Pernille Bjerre, MD, PhD, Omeed Neghabat, MD, Lone Juul Hune Mogensen, MStat, Niels Ramsing Holm, MD, Jouke Dijkstra, PhD, Evald Høj Christiansen, MD, PhD, Steen Hvitfeldt Poulsen, MD, PhD, DMSc, Hans Eiskjær, MD, PhD, DMSc.
Publikováno v:
JHLT Open, Vol 3, Iss , Pp 100038- (2024)
Background: Cardiac allograft vasculopathy (CAV) is a prevailing complication following heart transplantation. We aimed to investigate if CAV causes equal vascular remodeling in the major coronary arteries using quantitative optical coherence tomogra
Externí odkaz:
https://doaj.org/article/cd19b2bb13814159b0e1d6f92763b5cf